title: Acute antibiotic use in cystic fibrosis clinical trials: does it affect our assessment of clinical efficacy?
authors.affiliation: Department of Pediatrics, University of Washington, and Seattle Children's Hospital, Seattle, WA, USA. Electronic address: nicole.hamblett@seattlechildrens.org.
authors.forename: Nicole
authors.initials: N
authors.lastname: Mayer-Hamblett
authors.affiliation: Division of Respiratory Medicine, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Canada.
authors.forename: Felix
authors.initials: F
authors.lastname: Ratjen
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D018450:Disease Progression; D006801:Humans; D054539:Medication Therapy Management; D012137:Respiratory System / Q000187:drug effects / Q000503:physiopathology; D063189:Symptom Assessment / Q000379:methods / Q000592:standards; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents